Telmisartan and cardioprotection.

Vasc Health Risk Manag · 2011 · PMC3225351 · PMID 22140319

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In ONTARGET, telmisartan showed a trend to be slightly, but not significantly, more effective than ramipril in reducing LVH (OR: 0.92; 95% CI: 0.83–1.01; P = 0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.